LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Arvinas and Millions of Other Companies

Sign up for full access to Arvinas information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Key Personnel Promotions Arvinas recently promoted key personnel within the company, indicating a focus on internal talent development and growth opportunities. Engaging with these newly promoted individuals could lead to discussions around potential collaborations or partnerships aligned with the company's strategic direction.

Clinical Progression With multiple investigational drugs progressing through clinical development programs, Arvinas presents potential sales opportunities for suppliers of clinical trial services, specialized equipment, and supportive technologies. Engaging with the company at this stage can lead to discussions on tailored solutions to support their drug development efforts.

Technology Utilization Arvinas leverages a variety of technologies in its operations, including Microsoft Azure and modern data management tools. Technology providers offering complementary solutions or integration services have the opportunity to engage with Arvinas in discussions on enhancing operational efficiency and data management capabilities.

Financial Health With reported revenues between $50M - 100M and recent substantial funding of $350M, Arvinas indicates financial stability and potential for further growth and expansion. Service providers offering financial advisory, investment opportunities, or strategic partnership proposals could find opportunities to engage with Arvinas on leveraging their financial strength.

Market Expansion Arvinas' focus on developing therapies for serious diseases positions the company for potential market expansion into new disease areas or geographical regions. Sales development representatives can explore opportunities to introduce Arvinas to new market segments or support the company's entry into untapped markets through tailored solutions and market research offerings.

Similar companies to Arvinas

✕

Access Insights for Arvinas and Millions of Other Companies

Sign up for full access to Arvinas information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Arvinas Tech Stack

Arvinas uses 8 technology products and services including Drupal, Microsoft Excel, Font Awesome, and more. Explore Arvinas's tech stack below.

  • Drupal
    Content Management System
  • Microsoft Excel
    Editors
  • Font Awesome
    Font Scripts
  • IQVIA
    Health Platform
  • Modernizr
    Javascript Libraries
  • Microsoft Azure
    Platform As A Service
  • Hadoop
    Programming Languages
  • FedEx
    Transportation And Fleet Management

Media & News

Arvinas's Email Address Formats

Arvinas uses at least 1 format(s):
Arvinas Email FormatsExamplePercentage
First.Last@arvinas.comJohn.Doe@arvinas.com
96%
Last@arvinas.comDoe@arvinas.com
2%
First.Middle@arvinas.comJohn.Michael@arvinas.com
1%
Last.First@arvinas.comDoe.John@arvinas.com
1%

Frequently Asked Questions

Where is Arvinas's headquarters located?

Minus sign iconPlus sign iconArvinas's main headquarters is located at 395 Winchester Ave. 5 Science Park New Haven, Connecticut 06511 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Arvinas's phone number?

Minus sign iconPlus sign icon You can contact Arvinas's main corporate office by phone at
✕

Access Insights for Arvinas and Millions of Other Companies

Sign up for full access to Arvinas information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-203-535-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arvinas's stock symbol?

Minus sign iconPlus sign iconArvinas is a publicly traded company; the company's stock symbol is ARVN.

What is Arvinas's official website and social media links?

Minus sign iconPlus sign iconArvinas's official website is arvinas.com and has social profiles on LinkedIn.

How much revenue does Arvinas generate?

Minus sign iconPlus sign icon As of October 2024, Arvinas's annual revenue reached $75M.

What is Arvinas's SIC code NAICS code?

Minus sign iconPlus sign iconArvinas's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arvinas have currently?

Minus sign iconPlus sign iconAs of October 2024, Arvinas has approximately 447 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Scientific Officer: A. C.Chief Commercial Officer: J. N.Chief Medical Officer: R. P.. Explore Arvinas's employee directory with LeadIQ.

What industry does Arvinas belong to?

Minus sign iconPlus sign iconArvinas operates in the Biotechnology Research industry.

What technology does Arvinas use?

Minus sign iconPlus sign iconArvinas's tech stack includes DrupalMicrosoft ExcelFont AwesomeIQVIAModernizrMicrosoft AzureHadoopFedEx.

What is Arvinas's email format?

Minus sign iconPlus sign iconArvinas's email format typically follows the pattern of . Find more Arvinas email formats with LeadIQ.

How much funding has Arvinas raised to date?

Minus sign iconPlus sign icon As of October 2024, Arvinas has raised $350M in funding. The last funding round occurred on Nov 27, 2023 for $350M.

When was Arvinas founded?

Minus sign iconPlus sign iconArvinas was founded in 2013.
Arvinas

Arvinas

Biotechnology ResearchConnecticut, United States201-500 Employees

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma.

Based in the biotech hub of New Haven, CT, Arvinas is driven by an industry-leading team dedicated to improving the lives of people living with serious diseases. For more information, visit www.arvinas.com. 

Community Guidelines: http://bit.ly/ArvinasCG

✕

Access Insights for Arvinas and Millions of Other Companies

Sign up for full access to Arvinas information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
395 Winchester Ave. 5 Science Park New Haven, Connecticut 06511 US
Phone number
✕

Access Insights for Arvinas and Millions of Other Companies

Sign up for full access to Arvinas information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-203-535-****
Website
arvinas.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ARVN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $350M

    Arvinas has raised a total of $350M of funding over 4 rounds. Their latest funding round was raised on Nov 27, 2023 in the amount of $350M.

  • $50M$100M

    Arvinas's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $350M

    Arvinas has raised a total of $350M of funding over 4 rounds. Their latest funding round was raised on Nov 27, 2023 in the amount of $350M.

  • $50M$100M

    Arvinas's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Arvinas and Millions of Other Companies

Sign up for full access to Arvinas information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.